Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goff

Showing results (391-400 of 527) with videos related to

Pageof 53
Sort By:
Organic & Biomolecular Chemistry|August 17, 2016
6-Bromo-7-hydroxy-3-methylcoumarin (mBhc) is an efficient multi-photon labile protecting group for thiol caging and three-dimensional chemical patterningM Mohsen Mahmoodi, Stephanie A Fisher, Roger Y Tam, et al.
JAMA|August 23, 2012
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individualsJoseph Yeboah, Robyn L McClelland, Tamar S Polonsky, et al.
Brain Imaging and Behavior|August 5, 2020
Effect of DAOA genetic variation on white matter alteration in corpus callosum in patients with first-episode schizophreniaWenjun Su, Tianyuan Zhu, Lihua Xu, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 25, 2016
Higher pericardial adiposity is associated with prevalent diabetes: The Coronary Artery Risk Development in Young Adults studyA C Alman, D R Jacobs, C E Lewis, et al.
The Journal of Clinical Psychiatry|November 13, 2009
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapyJohn M Kane, Christoph U Correll, Donald C Goff, et al.
Schizophrenia Research|July 24, 2025
Hippocampal perfusion abnormalities and treatment effects in acute phase of first-episode schizophreniaHao Hu, Mengqing Xia, Lihe Chen, et al.
Atherosclerosis|June 13, 2006
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)Samia Mora, Moyses Szklo, James D Otvos, et al.
Psychological Medicine|July 8, 2011
Striatal function in relation to negative symptoms in schizophreniaS Ehrlich, A Yendiki, D N Greve, et al.
Nature|July 3, 1986
Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal locationB Royer-Pokora, L M Kunkel, A P Monaco, et al.
Journal of Clinical Psychopharmacology|June 19, 2013
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS studyDonald C Goff, Joseph P McEvoy, Leslie Citrome, et al.
Pageof 53

Showing results (391-400 of 527) with videos related to

Sort By:
Pageof 53
Organic & Biomolecular Chemistry|August 17, 2016
6-Bromo-7-hydroxy-3-methylcoumarin (mBhc) is an efficient multi-photon labile protecting group for thiol caging and three-dimensional chemical patterningM Mohsen Mahmoodi, Stephanie A Fisher, Roger Y Tam, et al.
JAMA|August 23, 2012
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individualsJoseph Yeboah, Robyn L McClelland, Tamar S Polonsky, et al.
Brain Imaging and Behavior|August 5, 2020
Effect of DAOA genetic variation on white matter alteration in corpus callosum in patients with first-episode schizophreniaWenjun Su, Tianyuan Zhu, Lihua Xu, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 25, 2016
Higher pericardial adiposity is associated with prevalent diabetes: The Coronary Artery Risk Development in Young Adults studyA C Alman, D R Jacobs, C E Lewis, et al.
The Journal of Clinical Psychiatry|November 13, 2009
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapyJohn M Kane, Christoph U Correll, Donald C Goff, et al.
Schizophrenia Research|July 24, 2025
Hippocampal perfusion abnormalities and treatment effects in acute phase of first-episode schizophreniaHao Hu, Mengqing Xia, Lihe Chen, et al.
Atherosclerosis|June 13, 2006
LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)Samia Mora, Moyses Szklo, James D Otvos, et al.
Psychological Medicine|July 8, 2011
Striatal function in relation to negative symptoms in schizophreniaS Ehrlich, A Yendiki, D N Greve, et al.
Nature|July 3, 1986
Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal locationB Royer-Pokora, L M Kunkel, A P Monaco, et al.
Journal of Clinical Psychopharmacology|June 19, 2013
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS studyDonald C Goff, Joseph P McEvoy, Leslie Citrome, et al.
Pageof 53